-
Loading metrics
Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
-
Yasuhiko Hattori,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing
Affiliation Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
⨯ -
Kazuhiko Kurozumi ,
Roles Conceptualization, Data curation, Funding acquisition, Methodology, Supervision, Validation, Writing – review & editing
* E-mail: kurozu20@hama-med.ac.jp
Affiliation Department of Neurosurgery, Hamamatsu University School of Medicine, Shizuoka, Japan
⨯ - Yoshihiro Otani,
- Atsuhito Uneda,
- Nobushige Tsuboi,
- Keigo Makino,
- Shuichiro Hirano,
- Kentaro Fujii,
-
Yusuke Tomita,
Roles Writing – review & editing
Affiliation Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
⨯ - Tetsuo Oka,
- Yuji Matsumoto,
- Yosuke Shimazu,
- Hiroyuki Michiue,
- Hiromi Kumon,
- Isao Date
https://orcid.org/0000-0003-3737-3604
Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
- Yasuhiko Hattori,
- Kazuhiko Kurozumi,
- Yoshihiro Otani,
- Atsuhito Uneda,
- Nobushige Tsuboi,
- Keigo Makino,
- Shuichiro Hirano,
- Kentaro Fujii,
- Yusuke Tomita,
- Tetsuo Oka
- Published: August 25, 2022
- https://doi.org/10.1371/journal.pone.0273242